CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
536.81 1.25(0.23%) NAV as on 30 Jul 2025
3.45 % 1 M
10.9 % 1 Y
24.95 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.80

As on 30 Jun, 2025
age-icon Age :

21 yrs 1 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,569.15 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

9.09

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2025
Others 0.53 %
Equity 99.47 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.23 %
Divi's Laboratories Ltd.8.50 %
Lupin Ltd.6.07 %
Cipla Ltd.5.62 %
Apollo Hospitals Enterprise Ltd.5.48 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs79.54
Hospital & Healthcare Services18.97
Business Support0.95
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)250.18290.14270.59428.87481.27
Net Assets(Rs Crores) (as on 31-Mar-2025) 4260.99 4931.89 4304.46 7125.28 8080.97
Scheme Returns(%)(Absolute)77.3614.83-6.8558.2410.94
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9030/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity536.811.25(0.23%)NAV As on 30 Jul, 202505-Jun-2004Inception Date8,569.15AUM In Cr.10.90%1Y24.95%3Y21.24%5Y20.71%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.470.07(0.17%)NAV As on 30 Jul, 202513-Jul-2018Inception Date5,727.59AUM In Cr.17.05%1Y29.50%3Y23.89%5Y22.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity444.965.06(1.15%)NAV As on 30 Jul, 202514-Jul-1999Inception Date3,849.24AUM In Cr.16.99%1Y28.30%3Y23.68%5Y16.41%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.390.16(0.52%)NAV As on 30 Jul, 202528-Dec-2015Inception Date1,281.99AUM In Cr.9.88%1Y24.31%3Y21.03%5Y12.66%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors